Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cogent Biosciences (COGT) Depreciation & Amortization (CF) (2017 - 2021)

Historic Depreciation & Amortization (CF) for Cogent Biosciences (COGT) over the last 5 years, with Q4 2021 value amounting to $68000.0.

  • Cogent Biosciences' Depreciation & Amortization (CF) rose 30000.0% to $68000.0 in Q4 2021 from the same period last year, while for Dec 2021 it was $147000.0, marking a year-over-year decrease of 7958.33%. This contributed to the annual value of $2.5 million for FY2024, which is 869.57% up from last year.
  • Per Cogent Biosciences' latest filing, its Depreciation & Amortization (CF) stood at $68000.0 for Q4 2021, which was up 30000.0% from $48000.0 recorded in Q3 2021.
  • Cogent Biosciences' Depreciation & Amortization (CF)'s 5-year high stood at $352000.0 during Q4 2018, with a 5-year trough of $14000.0 in Q2 2021.
  • Moreover, its 5-year median value for Depreciation & Amortization (CF) was $297500.0 (2017), whereas its average is $232600.0.
  • The largest annual percentage gain for Cogent Biosciences' Depreciation & Amortization (CF) in the last 5 years was 30000.0% (2021), contrasted with its biggest fall of 9510.49% (2021).
  • Cogent Biosciences' Depreciation & Amortization (CF) (Quarter) stood at $307000.0 in 2017, then grew by 14.66% to $352000.0 in 2018, then decreased by 10.8% to $314000.0 in 2019, then plummeted by 94.59% to $17000.0 in 2020, then soared by 300.0% to $68000.0 in 2021.
  • Its last three reported values are $68000.0 in Q4 2021, $48000.0 for Q3 2021, and $14000.0 during Q2 2021.